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Inorganic sodium arsenite (iAs), a ubiquitous
element, is one of the most toxic metals pre-
sent in the natural environment (Bagla and
Kaiser 1996). Arsenicals are found as naturally
occurring constituents of soil, food, and drink-
ing water (Wu et al. 1989; Yoshida et al.
2004), and exposure to iAs has been associated
with a variety of disease outcomes, including
disorders of the skin, urinary bladder, liver,
and lung (Tchounwou et al. 2004). In particu-
lar, skin hyperkeratosis is a characteristic der-
matologic lesion associated with ingestion of
arsenic from contaminated groundwater
(McLellan 2002; Yoshida et al. 2004). There is
also a significant association between hyper-
keratosis, nonmelanoma skin cancer (e.g., basal
cell carcinoma and squamous cell carcinoma),
and Bowen disease (Col et al. 1999; Rossman
et al. 2004). Furthermore, the pathologic fea-
tures associated with arsenic-induced hyper-
keratosis present as typical acanthotic types of
psoriasis-like keratosis, characterized by the
aberrant proliferation and terminal differentia-
tion of epidermal keratinocytes (Lee et al.
2006). Many epidemiologic studies have
shown that hyperkeratoses are the most fre-
quent precursor lesions of some skin cancers
(Bagla and Kaiser 1996; Col et al. 1999).
The keratins are the most prominent
cytoskeletal proteins in keratinocytes and com-
prise a large family of proteins that form inter-
mediate ﬁlament networks in all epithelial cell
types (Moll et al. 1982). Keratin 16 (K16 ) and
keratin 6 (K6) genes are constitutively expressed
in a number of stratified epithelial levels,
including the palmar and plantar epidermis
(Moll et al. 1982). In skin diseases character-
ized by aberrant proliferation and differentia-
tion, such as psoriasis and cancer, K16 is
detectable at higher levels compared with nor-
mal tissue (Haider et al. 2006). Furthermore,
the tissue-speciﬁc overexpression of wild-type
K16 in the epidermis of transgenic mice results
in the hyperproliferation of keratinocytes and
aberrant keratinization of corniﬁed layers, lead-
ing to hyperkeratosis of the skin (Takahashi
et al. 1994).
Nuclear factor erythoid-derived 2 related
factor 2 (NRF2), a “cap ’n’ collar” basic leucine
zipper transcription factor, regulates a transcrip-
tional program that maintains cellular redox
homeostasis and protects cells from oxidative
stress and xenobiotic agents (Ishii et al. 2000;
Moi et al. 1994). Several detoxifying and
antioxidant genes, including glutathione-
S-transferases (GSTs), heme oxygenase-1
(HMOX1), and thioredoxin (TXN), are regu-
lated by NRF2 through the antioxidant respon-
sive element (ARE) in the respective promoter
regions of these genes (McMahon et al. 2001;
Wakabayashi et al. 2004). NRF2 is held in the
cytoplasm by a cytoskeletal-associated speciﬁc
inhibitory protein (kelch-like ECH-associated
protein 1; KEAP1) under normal cellular redox
state conditions, where it is continuously tar-
geted by the proteasomal degradation pathway
(McMahon et al. 2003). Upon exposure of the
cell to oxidative stress or electrophiles, NRF2
can escape this KEAP1-mediated repression,
translocate to the nucleus, and activate the
expression of its target genes (Dinkova-Kostova
et al. 2002; McMahon et al. 2003).
Recently, studies of Keap1–/–mice have
shown that NRF2 accumulates in the nucleus
and constitutively activates the transcription
of its target genes, even in the absence of
stress signals (Wakabayashi et al. 2003). Most
interestingly, however, the skin, esophagus,
and forestomach of Keap1-deficient mice
show cornified layer and hyperkeratosis
phenotypes. In addition, previous studies
have also shown that the expression of NRF2
and ARE-controlled genes is induced by iAs
in some cell types (Pi et al. 2003; Sakurai
et al. 2005). Furthermore, histochemical
analyses have indicated that the expression of
K16 is increased in Bowen disease, basal cell
carcinoma, and squamous cell carcinoma
induced by arsenicals (Yu et al. 1993).
However, it remains to be determined
whether NRF2 can regulate the transcrip-
tional activation of K16 upon iAs exposure in
human keratinocytes. Hence, these findings
prompted us to investigate the molecular
mechanisms underlying the regulation of the
K16 gene by iAs-induced NRF2 mediation.
Materials and Methods
Chemicals and reagents. A puriﬁed preparation
of inorganic sodium arsenite (iAs; NaAsO2;
Merck, Darmstadt, Germany) was dissolved in
phosphate-buffered saline (PBS) and added
directly to the culture medium. A fresh iAs
solution was prepared for each new experi-
ment. Cycloheximide (CHX), dimethyl-
sulfoxide (DMSO), and a protease inhibitor
cocktail were purchased from Sigma (St. Louis,
MO, USA). CHX was dissolved in DMSO
and stored –20°C until use.
Cells and culture conditions. The human
keratinocyte HaCaT cell line was obtained
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BACKGROUND: Inorganic sodium arsenite (iAs) is a ubiquitous environmental contaminant and is
associated with an increased risk of skin hyperkeratosis and cancer.
OBJECTIVES: We investigated the molecular mechanisms underlying the regulation of the keratin 16
(K16) gene by iAs in the human keratinocyte cell line HaCaT.
METHODS: We performed reverse transcriptase polymerase chain reaction, luciferase assays, Western
blots, and electrophoretic mobility shift assays to determine the transcriptional regulation of the K16
gene by iAs. We used gene overexpression approaches to elucidate the nuclear factor erythroid-
derived 2 related factor 2 (NRF2) involved in the K16 induction.
RESULTS: iAs induced the mRNA and protein expression of K16. We also found that the expression
of K16 was transcriptionally induced by iAs through activator protein-1–like sites and an antioxi-
dant response element (ARE) in its gene promoter region. Treatment with iAs also enhanced the
production and translocation of the NRF2 transcription factor, an ARE-binding protein, into the
nucleus without modiﬁcation of its mRNA expression. In addition, iAs elongated the half-life of
the NRF2 protein. When overexpressed in HaCaT cells, NRF2 was also directly involved in not
only the up-regulation of the detoxiﬁcation gene thioredoxin but also K16 gene expression.
CONCLUSIONS: Our data clearly indicate that the K16 gene is a novel target of NRF2. Furthermore,
our ﬁndings also suggest that NRF2 has opposing roles in the cell—in the activation of detoxiﬁca-
tion pathways and in promoting the development of skin disorders.
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Center, Heidelberg, Germany). Cells were
maintained in monolayer cultures in 95% air
and 5% CO2 at 37°C in Dulbecco’s modiﬁed
Eagles medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 50 U/mL
penicillin and 50 mg/mL streptomycin and
nonessential amino acids (Gibco BRL,
Paisley, UK).
RNA preparation and semiquantitative
reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis. We determined RNA
expression levels by semiquantitative RT-PCR
analysis as described previously (Sugioka et al.
2004). Total RNA was isolated from HaCaT
cells using the GeneElute Mammalian Total
RNA Kit (Sigma). The speciﬁc primers used for
ﬁrst-strand cDNA synthesis and PCR were as
follows: K16 [forward, 5´-GAT GCT TGC
TCT GAG AGG TC-3´, and reverse, 5´-CCA
GCA AGA TCT GGT ACT CC-3´; Gene
Bank accession no. NM_005557 (National
Center for Biotechnology Information 2007)];
c-Jun (forward, 5´-CCT GTT GCG GCC
CCG AAA CT-3´, and reverse, 5´-ACC ATG
CCT GCC CCG TTG AC-3´; NM_002228);
c-Fos (forward, 5´-TTT GCC TAA CCG CCA
CGA TGA T-3´, and reverse, 5´-TTG CCG
CTT TCT GCC ACC TC-3´; NM_005252);
NRF2 (forward, 5´-AGA TTC ACA GGC
CTT TCT CG-3´, and reverse, 5´-CAG CTC
TCC CTA CCG TTG GA-3´; AF323119);
KEAP1 (forward, 5´-CAG AGG TGG TGG
TGT TGC TTA T-3´, and reverse, 5´-AGC
TCG TTC ATG ATG CCA AAG-3´;
NM_012289); TXN (forward, 5´-CAG GGG
AAT GAA AGA AAG G-3´, and reverse,
5´-CAA GGT GAA GCA GAT CG-3´;
NM_003329), and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a loading control
(forward, 5´-ACC ACA GTC CAT GCC
ATC AC-3´, and reverse, 5´-TCC ACC ACC
CTG TTG CTG TA-3´, NM_002046). PCR
products were separated on a 1.8% agarose gel
and stained with ethidium bromide.
Western blot analysis. We performed
Western blot analysis as described previously
(Sugioka et al. 2004). Brieﬂy, nuclear and cyto-
plasmic proteins were extracted using the
NE-PER nuclear and cytoplasmic extraction kit
(Pierce, Rockford, IL, USA) according to the
manufacturer’s protocol. For protein extraction,
the cells were lysed in a buffer containing com-
plete protease inhibitor cocktail. We measured
protein concentrations using the DC Protein
Assay Kit (Bio-Rad, Richmond, CA, USA).
Equal amounts of protein were then resolved by
sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to a
polyvinylidene ﬂuoride membrane (Amersham
Biosciences, Bucks, UK). Immunoblotting was
carried out with specific antibodies in Tris-
buffered saline with 0.05% Tween 20. The pri-
mary antibodies were as follows: K16
(Neomarkers, Fremont, CA, USA), NRF2 and
KEAP1 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), c-Jun (Cell Signaling,
Beverly, MA, USA), and β-actin (Sigma). After
washing, the membranes were probed with
horseradish peroxidase-conjugated secondary
antibodies and developed by chemilumines-
cence using the ECL Plus Detection Kit
(Amersham Biosciences). 
Plasmids, transfections, and luciferase
assays. Human K16 promoter regions of vary-
ing lengths (pXK-1, 3, 4, 5-1, and 5-2) were
provided by Y-N Wang (National Cheng Kung
University, Taiwan). These DNA fragments
were prepared from HaCaT cells and were lig-
ated into the pXP-1 luciferase vector (Wang
and Chang 2003). The p3xARE/Luc vector,
harboring three tandem repeats of ARE, was
donated by X.L. Chen (Discovery Research,
AtheroGenics Inc., Alpharetta, GA, USA)
(Chen et al. 2003). The wild-type NRF2
expression vector (WT-NRF2) was a gift from
H.S. So (Wonkwang University School of
Medicine, Korea) (So et al. 2006). NRF2
cDNA was subcloned into a pcDNA3.1(+) vec-
tor (Invitrogen, San Diego, CA, USA). For the
transfection of reporter plasmids, we seeded
HaCaT cells into six-well plates at a density of
80% the previous day. Cells were then trans-
fected with a total of each luciferase reporter
construct (2.5 µg) using LipofectAMINE plus
(Invitrogen). To control for the efﬁciency of
transfection, Renilla luciferase gene expression
was monitored using either the pRL-CMV or
pRL-TK vectors (Promega, Madison, WI,
USA). For overexpression of WT-NRF2, we
normalized the total plasmid concentration
using the pcDNA3.1(+) empty vector. Thirty-
six hours after transfection, the medium was
replaced with fresh medium containing either
vehicle (PBS) or iAs for 6 hr. After iAs expo-
sure, we harvested cells and analyzed them for
luciferase activity using a Dual-Luciferase
Reporter Assay System (Promega).
For the investigation of the role of NRF2
in regulating K16 gene expression, transfection
of an NRF2 expression plasmid into HaCaT
cells was carried out using LipofectAMINE
2000 (Invitrogen). Cells were cultured in
100-mm plates 24 hr before transfection. The
expression plasmid WT-NRF2 (15 µg) was
then transfected into the cells for 48–60 hr. As
a negative control, we used 15 µg of the
pcDNA3.1(+) empty vector. 
Electrophoretic mobility-shift assays
(EMSA). We extracted and measured nuclear
proteins as described above. Nuclear protein/
DNA complexes were subjected to electro-
phoresis in nondenaturing 5% polyacrylamide
gels containing 2% glycerol in 0.25% Tris-
borate/EDTA buffer and transferred to
Hybond-N+ nylon transfer membranes
(Amersham Biosciences) for detection using the
Light-Shift EMSA kit (Pierce) according to the
manufacturer’s protocol, with minor modiﬁca-
tions. We incubated 10-µg aliquots of nuclear
extract with the DNA probe in a binding reac-
tion buffer containing 10 mM Tris/HCl
(pH 7.6), 50 mM KCl, 0.5 mM dithiothreitol,
0.25 mM EDTA, 5% glycerol, 2.5 mM
MgCl2, 0.05% NP-40 detergent, and 2 µg of
poly(dI-dC)⋅poly(dI-dC) for 30 min at room
temperature. For supershift assays, 2 µg of
either a polyclonal anti-NRF2 or an anti-c-Jun
antibody (Santa Cruz Biotechnology) was
added with the nuclear protein for 2 hr at 4°C
before the labeled oligonucleotide probe was
added. Biotin-labeled, double-stranded oligo-
nucleotides WT-K16ARE (–157/–132,
5´-GGGGAACCTGGAGTCAGCAGT-
TAGGA-3´), containing an ARE site (–148/
–140, underlined) in the human K16 promoter
region, and Mut-K16ARE (5´-GGGGAA-
CCTGGAGTCAaaAGTTAGGA-3´, mutated
GC box in the ARE) were prepared by Fasmac
(Kanagawa, Japan). A consensus ARE probe
Endo et al.
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Figure 1. Dose-dependent effects of iAs on the expression of K16 in HaCaT cells maintained in serum-free
medium for 24 hr and then treated with iAs at various concentrations for 6 or 24 hr (A) or 6, 10, or 24 hr (B).
Con, control. (A) After iAs treatment, total RNA was extracted from the cells, and 1-µg aliquots were ampli-
ﬁed by semiquantitative RT-PCR using K16 primers; GAPDH was ampliﬁed as an internal control. (B) Equal
amounts of total protein extracts from the cells were subjected to Western blot analysis for K16; β-actin
expression was analyzed as a loading control. 
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GAPDHwas purchased from Panomics, Inc. (Redwood
City, CA, USA). For competition binding of
the K16 ARE-complexes, we used an unlabeled
AP-1 consensus oligonucleotide (5´-TATC-
GATAAGCTATGAGTCATCCGGG-3´).
The binding speciﬁcity was conﬁrmed in each
case by the addition of a 100-fold molar excess
of unlabeled oligonucleotide.
CHX chase experiment. We investigated
the posttranscriptional regulation of both the
steady-state levels and half-life of the NRF2
protein by CHX chase analysis. Cells were
incubated in serum-free medium in the
absence or presence of iAs for 6 hr. The culture
medium was then replaced with serum-free
medium containing CHX (100 µg/mL). We
prepared cell lysates at 0, 10, 30, 60, 120, and
240 min after iAs treatment. Whole-cell lysates
were resolved by SDS-PAGE and immuno-
blotted with antibodies against NRF2.
Statistics. All the data generated from at
least three independent experiments and
expressed as the mean ± SD were analyzed by
the Student’s t-test. Statistical comparisons
were made by logarithmic transformation of
the normalized values. We considered p-values
< 0.01 to be statistically signiﬁcant.
Results
K16 expression is induced by iAs in HaCaT
cells. We wanted to determine whether the
K16 mRNA is transcriptionally regulated by
iAs, and treated HaCaT cells with this com-
pound for various time periods over a range of
doses. After treatment of HaCaT cells with
1–20 µM iAs, the expression of K16 mRNA
was increased compared with the control at
6 hr (Figure 1A) but had declined to basal lev-
els at 24 hr. The increase in the K16 protein
levels after 6 hr of iAs exposure was just
detectable at 10–20 µM, but a dose-dependent
increase was more evident at 10 hr (Figure 1B).
This enhancement of K16 expression had
declined to basal levels at 24 hr.
Identiﬁcation of the iAs responsive region
in the K16 gene promoter. To investigate the
mechanisms underlying the transactivation of
the K16 gene by iAs, we first examined the
response of the K16 regulatory region to this
compound using a luciferase reporter gene
assay. The dose-dependent activation of K16
transcription after iAs treatment was observed
with a construct containing a 515-bp fragment
of the K16 promoter (Figure 2A). To further
elucidate the region containing the iAs respon-
sive element, we examined a series of deletions
of the 5´-flanking region of K16 gene. The
ARE sequence in the pXK-5–1 vector contains
an activator protein-1 (AP-1)–like element fol-
lowed by a GC box. As shown in Figure 2B, an
enhancement in the reporter activity levels was
observed for the promoter constructs, pXK-1,
3, 4, and 5-1, in response to 20 µM iAs. A
decline in reporter activity, however, depended
on the number of AP-1–like sites, and the
results for the pXK-5-1 construct show also
that ARE is activated by iAs. In contrast, no
significant activation was observed using a
pXK-5-2 construct in response to 20 µM iAs.
Expression of AP-1 transcriptions factor
and c-Jun production following iAs treatment.
We examined AP-1 transcription factors c-Jun
and c-Fos expression in iAs-treated HaCaT
cells by semiquantitative RT-PCR. iAs-
induced c-Jun expression was observed during
the ﬁrst 3 hr after treatment (data not shown).
An appreciable induction of c-Jun was also
conﬁrmed after 6 hr, but this was down-regu-
lated by 24 hr after iAs treatment (Figure 3A).
In contrast, the expression of c-Fos was only
transiently detectable at 3 hr (data not shown)
but was not observed during the 6–24 hr
Arsenic induces NRF2-mediated keratin 16 gene expression
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Figure 2. Response of the K16 regulatory region to iAs using a luciferase reporter gene assay, with relative luciferase activities normalized for pRL-CMV activity
and calculated as a percentage of the promoter activity in HaCaT cells without iAs exposure (control). Abbreviations: +, presence; –, absence; Con, control.
(A) Transcriptional activation of K16 gene by iAs (left) and the luciferase reporter gene construct harboring the –515-bp K16 gene promoter region (pXK-1; right). (B)
Luciferase activity of the iAs responsive region in the K16 gene promoter in cells cotransfected with individual reporter constructs harboring various deletions of
the 5´-ﬂanking region of the K16 gene promoter (left) and normalized for pRL-CMV, and the luciferase reporter gene constructs for individual promoter regions
(right). See “Materials and Methods” for details of experiments. The values shown indicate the ratio of the luciferase activities in untreated cells and in cells
treated with 20 µM iAs for 6 hr; luciferase activity with no treatment was deﬁned as 100%. Values represent the mean ± SD of ﬁve to eight independent experi-
ments, each run in triplicate. Each p-value was obtained by t-test following logarithmic transformation of normalized values. 
*p < 0.01, and **p < 0.001 compared with the untreated group. 
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Figure 3. Effects of iAs on the expression of AP-1 transcription factors in HaCaT cells maintained in serum-
free medium for 24 hr and then treated with iAs. Con, control. (A) Expression of c-Jun, c-Fos, and GAPDH
genes examined by semiquantitative RT-PCR at 6 and 24 hr; GAPDH gene expression was analyzed as a
loading control. (B) Western blot analysis of nuclear extracts from cells 6, 10, or 24 hr after iAs treatment
using c-Jun and β-actin antibodies. Equal protein loading was conﬁrmed by β-actin expression. Results
were obtained from three independent experiments. 
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6 hrperiod of this experiment. As shown in Figure
3B, iAs-enhanced c-Jun production can be
observed in a dose-dependent manner at 6 hr,
but it declines from 10 to 24 hr.
iAs potently induces the translocation of
NRF2 and activates the ARE of the K16 pro-
moter. The results of our reporter assays sug-
gested that iAs stimulates not only the AP-1–
like sites but also the ARE site within the K16
gene promoter in HaCaT cells (Figure 3). In
addition, several oxidative stress agents and
toxic chemicals, including iAs, have been
reported to induce the expression of ARE-
dependent genes in several cell types (Pi et al.
2003; Sakurai et al. 2005). On the basis of our
observations and some recent reports, we thus
hypothesized that iAs would have the ability
to activate the ARE of the K16 gene promoter
directly, resulting in the induction of K16
expression in HaCaT cells. To confirm that
the K16 ARE indeed functions as an iAs-
responsive transcriptional control element, we
performed transient transfections of HaCaT
cells with a p3xARE/Luc construct and then
subjected these cells to iAs for 6 hr. As shown
in Figure 4A, treatment of HaCaT cells with
iAs results in a dramatic increase in ARE-
driven promoter activity. Likewise, EMSA
using a consensus ARE probe show that iAs-
induced ARE-binding complexes increase
markedly, in a dose-dependent fashion
(Figure 4B). These results indicate that iAs has
the ability to activate the ARE-driven genes.
We performed further EMSA experiments
using an ARE probe speciﬁc to the K16 proxi-
mal promoter region (WT-K16ARE) and
found that K16ARE–nuclear protein com-
plexes formation is augmented by iAs in a dose-
dependent manner (Figure 4C). Moreover, the
formation of these complexes is specifically
inhibited by the addition of excess unlabeled
oligonucleotide competitor (Figure 4B,C),
whereas an excess of an unlabeled AP-1 probe
competes only marginally for K16ARE binding
(Figure 4C).
The NRF2 transcription factor has been
shown to bind to AREs upon translocation into
the nucleus, resulting in the induction of ARE-
mediated genes (Wakabayashi et al. 2004). To
examine whether iAs induces and translocates
NRF2 into the nucleus in HaCaT cells, we
treated these cells with iAs for either 3 or 6 hr.
As shown in Figure 4D, a dose-dependent
accumulation of NRF2 protein was observed in
the nucleus upon treatment with iAs for 6 hr.
This was not observed in the parallel experi-
ment performed over the 3-hr time course.
Supershift EMSA analysis using an NRF2
antibody showed that the iAs-induced and
iAs-translocated NRF2 protein binds to the
WT-K16ARE probe containing the ARE
sequence of the K16 proximal promoter region
(5´-GGAGTCAGC-3´) that comprises an
AP-1–like site and a GC box, whereas the
supershift of c-Jun was not observed
(Figure 4E). To identify whether the GC box is
dispensable for the iAs-stimulated binding
activity of NRF2, we next performed EMSA
analyses with either WT- or a Mut-K16ARE
probe containing an intact AP-1–like element
but a mutated GC box. As shown in Figure 4F,
the K16ARE–nuclear protein complexes and
supershifted bands that were enhanced by iAs
treatment were largely abolished by the addi-
tion of the Mut-K16ARE probe.
iAs stabilizes the NRF2 protein. We
examined the effects of iAs treatment on the
function of KEAP1 in HaCaT cells.
Treatment with iAs did not alter the expres-
sion levels of KEAP1 mRNA or protein over
either a 3 or 6 hr time course (Figure 5A).
Next, we examined the effects of iAs on the
Endo et al.
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Figure 4. iAs potently stimulates the ARE and induces production and translocation of NRF2 into the
nucleus of HaCaT cells. Abbreviations: +, presence; –, absence; Con, control. (A) Effect of iAs on ARE-driven
promoter activity determined using cotransfection of the p3xARE/Luc reporter gene construct (shown
schematically in the lower panel), containing three copies of the ARE, into HaCaT cells with the pRL-TK
vector encoding Renilla luciferase. See “Materials and Methods” for details. Values shown indicate the
ratio of the luciferase activities in untreated cells and in cells treated with 20 µM iAs for 6 hr; luciferase
activity with no treatment was defined as 100%. Values represent the mean ± SD of three independent
experiments, each run in triplicate. (B) Results of EMSA analyses performed using iAs-stimulated nuclear
extracts and a biotinylated consensus ARE probe. The arrow indicates the consensus ARE probe-nuclear
protein band shifts; an unlabeled consensus ARE probe was used as a competitor oligo. (C) EMSA of
nuclear extracts prepared from cells treated with iAs for 6 hr using a biotinylated WT-K16ARE probe
(5´-GGGGAACCTGGAGTCAGCAGTTAGGA-3´, with the wild-type ARE sequence found in the K16 promoter
from –157 to –132 bp underlined). An unlabeled WT-K16ARE probe was used as a competitor. To determine
the binding specificity of ARE, an unlabeled AP-1 oligonucleotide was added to the iAs-treated nuclear
extracts before the addition of the labeled WT-K16ARE probe. The arrow indicates shifted K16ARE-nuclear
protein complexes. (D) Nuclear accumulation of NRF2 stimulated by iAs in HaCaT cells maintained in
serum-free medium for 24 hr and then treated with iAs for 3 or 6 hr. Cytoplasmic and nuclear extracts were
then prepared and subjected to Western blot analysis using polyclonal NRF2 antibodies; results shown
represent three independent experiments. (E) Regulation of the ARE site within the K16 gene promoter
after iAs treatment. The WT-K16ARE probe was incubated with nuclear extracts prepared from cells cul-
tured in the absence (–) or presence (+) of 20 µM iAs for 6 hr. For supershift EMSA analysis, the nuclear
extracts were incubated with either an anti-NRF2 or anti-c-Jun antibody before the addition of labeled
probe. The binding speciﬁcity was conﬁrmed by the addition of excess unlabeled WT-K16ARE probe. The
arrow indicates shifted complexes, and double arrowheads indicate supershifted K16ARE-NRF2 com-
plexes. (F) In a similar experiment to the one shown in (E), either a WT-K16ARE or Mut-K16ARE probe was
incubated with nuclear extracts of cells cultured in the presence of 20 µM iAs for 6 hr. The GC box of Mut-
K16ARE was substituted with AA as indicated. Anti-NRF2 antibody was used in the supershift assays. The
arrows and double arrowheads indicate shifted and supershifted complexes, respectively.
aNonspeciﬁc band. 
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Exposure to iAs did not signiﬁcantly alter the
steady-state levels of NRF2 mRNA (data not
shown). Production of NRF2 protein, how-
ever, was observed to increase in both a dose-
and time-dependent manner (Figure 4D). To
further examine the stabilization of NRF2
protein by iAs, we monitored the decay of
basal and iAs-induced NRF2 proteins after
inhibition of protein synthesis by CHX
(Figure 5B). The results of this analysis
revealed that the NRF2 protein levels decrease
by approximately 50% within 30 min of
treatment with CHX in cells that had not
been exposed to iAs. Only trace amounts of
NRF2 are then detectable after 60 min of
exposure to CHX in these cells. The HaCaT
cells were then pretreated with iAs for 6 hr
before their exposure to CHX in a similar
timecourse experiment. The levels of NRF2
in these iAs-treated cells were again found to
decrease by about 50%, but only after
120 min of CHX exposure.
NRF2 plays a crucial role in the regula-
tion of K16 gene expression in HaCaT cells.
To confirm the functional role of NRF2 in
the induction of K16 gene expression by iAs,
we investigated whether the expression of
K16 mRNA is induced by the overexpression
of NRF2 (WT-NRF2) in HaCaT cells. We
also investigated the expression of the detoxi-
fication gene TXN, which is highly induced
by a variety of oxidative stimuli through
NRF2-mediated ARE transactivation (Kim
et al. 2001). The expression of TXN gene in
untransfected cells after treatment with iAs
was stronger than that of the control cells
(Figure 6A). When the cells were transfected
with WT-NRF2 and then treated with or
without iAs, the expression of TXN mRNA
was augmented markedly compared with the
empty-vector control. Similarly, the expres-
sion of K16 mRNA was also induced in cells
transfected with WT-NRF2 in the absence or
presence of iAs. We next performed a tran-
sient transfection of HaCaT cells with the
pXK-5–1 luciferase vector together with the
WT-NRF2 vector. The overexpression of
NRF2 in increasing concentrations resulted in
signiﬁcant enhancement of the ARE-mediated
K16 promoter activation (Figure 6B).
Discussion
In the present study, we showed for the ﬁrst
time that iAs induces the transcriptional activa-
tion of K16 in the human keratinocyte cell
line, HaCaT, through the ARE present in its
gene promoter. It has been reported previously
that treatment with iAs enhances the produc-
tion and translocation of NRF2 into the
nucleus in several cell types. However, until
now it has remained uncertain whether the
induction of NRF2 by iAs mediates the
transcriptional activation of the K16 gene in
keratinocytes. In our current experiments, we
demonstrated that iAs elongates the half-life of
the NRF2 protein, which results in its
increased expression levels. Furthermore, this
iAs-induced NRF2 protein was shown to bind
to the ARE sequences in the promoter region
of the K16 gene. Finally, by overexpressing
NRF2, we have clariﬁed that its induction is
involved in not only the gene expression of the
detoxiﬁcation gene TXN, but also in the upreg-
ulation of K16 expression in HaCaT cells
through the ARE in the K16 gene promoter.
These experiments indicate an important and
novel function for NRF2 in the regulation of
K16 in keratinocytes and also help to further
explain the molecular mechanisms underlying
arsenic-mediated epidermal hyperkeratosis.
In our present experiments, the expression
levels of K16 mRNA and protein were indeed
found to be enhanced by iAs in a dose-
dependent manner (Figure 1). In addition,
luciferase assays of the K16 promoter revealed
that iAs enhances its activity in a dose-
dependent fashion, which is stimulated by
AP-1–like sites and an ARE (Figure 2). The
promoter of the human K16 gene was recently
cloned and sequenced, and several AP-1–like
sites were found within the –515-bp region of
the gene (Wang and Chang 2003). AP-1 tran-
scription factor can be formed by the dimeriza-
tion of either Jun or Jun/Fos family members
(Eferl and Wagner 2003). In the present study,
the increased expression of c-Jun, but not c-Fos
was evident in the nuclei of HaCaT cells after
iAs treatment (Figure 3). Our ﬁndings thus sug-
gest that the activation of c-Jun/AP-1 is one of
the essential steps in the regulation of K16 gene
expression by iAs exposure in HaCaT cells.
It has been well documented that the
ARE core sequence includes an AP-1–like
binding site (TGAC/GTCA), followed by a
GC box (Rushmore et al. 1991; Xie et al.
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Figure 5. iAs enhances the stability of the NRF2 protein. Abbreviations: +, presence; –, absence; Con, con-
trol. (A) Expression levels of KEAP1 and GAPDH mRNA determined by semiquantitative RT-PCR in HaCaT
cells cultured in serum-free medium for 24 hr and then treated with iAs for 3 or 6 hr (upper panels); cyto-
plasmic extracts from iAs-treated cells were subjected to Western blot analysis for KEAP1 and β-actin
(lower panels). (B) Posttranscriptional regulation of both the steady-state level and half-life of NRF2 pro-
tein shown by Western blot analysis (see “Materials and Methods” for details). β-Actin was used as an
internal control. Similar results were obtained from three independent experiments. 
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Figure 6. NRF2 directly induces the K16 gene in HaCaT cells. Abbreviations: +, presence; –, absence; Con,
control. (A) Cells were transiently transfected with empty vector pcDNA3.1 (control) or expression vector
WT-NRF2 as described in “Materials and Methods,” and the expression of TXN, K16, and GAPDH was exam-
ined by semiquantitative RT-PCR using GAPDH expression levels as an internal control. (B) Cells were trans-
fected with WT-NRF2, together with the pXK-5–1 and the Renilla luciferase vector pRL-TK (the pXK-5-1
luciferase vector is shown schematically in the lower panel). Transfected cells were incubated for 48 hr and
then analyzed for luciferase activity as described in “Materials and Methods.” Luciferase activity in cells
transfected with pcDNA3.1 was set as 100%. The values represent the mean ± SD of four independent trans-
fection experiments, each run in triplicate. We obtained p-values by t-tests following logarithmic transforma-
tion of normalized values. 
**p < 0.01 compared with the control group (pcDNA3.1). 
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Luc1995). We have found in our current analy-
ses that the AP-1–like site within the K16
promoter region from –148 to –140 bp
(5´-GGAGTCAGC-3´) resembles a consen-
sus ARE sequence. Recent studies have
shown that AREs can be specifically bound
by complexes of several basic-leucine zipper
transcription factors, including NRF2 (Ishii
et al. 2000; Moi et al. 1994). NRF2 heter-
odimerizes with either AP-1 or small MAF
(MAFG, MAFK, and MAFF) proteins (MAF,
v-maf musculoaponeurotic fibrosarcoma
oncogene homolog) and binds to the ARE to
induce the transcription of ARE-mediated
genes (Motohashi et al. 2002). In the present
investigation, EMSA and supershift assays
showed that the NRF2 proteins in the nuclei
bind to the ARE sequences of K16 promoter
region after iAs exposure. iAs-induced c-Jun,
however, does not bind to this ARE (Figure
4E). c-Jun may thus act on other AP-1 sites
within the K16 promoter region. These results
also suggest that other heterodimer partners of
NRF2 are involved in the ARE regulation of
K16 promoter region underlying iAs-mediated
the K16 gene expression. Gel shifts with an
K16Mut-ARE probe (harboring a mutation in
the ARE GC box) clearly show that the ARE
sequence in the K16 promoter, particularly the
terminal GC dinucleotide, is essential for
mediating iAs-induced K16 transactivation
and NRF2 binding (Figure 4F). Several inves-
tigations have suggested that the GC
nucleotides within the ARE are essential for
both the basal and oxidative stress–induced
activities of the ARE-related genes, NAD(P)H
dehydrogenase quinone 1 (NQO1) and gluta-
mate-cysteine ligase catalytic subunit (GCLC)
(Wasserman and Fahl 1997; Wild et al.
1998). Our current results are consistent with
these earlier studies in showing that the forma-
tion of the iAs-responsive NRF2/ARE com-
plexes is reduced by a mutation in the GC
box. Collectively, our present observations
reveal a new molecular mechanism in which
iAs-induced K16 gene expression is also regu-
lated by activation NRF2/ARE pathways.
It has been widely accepted that oxidative
stress disrupts sequestration of NRF2 by
KEAP1, permits NRF2 translocation to the
nucleus, and transactivates the expression of
various NRF2-mediated genes (Dinkova-
Kostova et al. 2002; McMahon et al. 2003).
Our present study showed that iAs elongates
the half-life of the NRF2 protein but has no
effects upon KEAP1 expression (Figure 5).
Other studies have also demonstrated that the
production of NRF2 is increased by various
inducers via posttranscriptional control
(Nguyen et al. 2003; Stewart et al. 2003).
Several earlier reports also indicated that
either oxidative stress or antioxidant sub-
stances stabilize the expression of the NRF2
protein, either by directly modifying the
cysteine residues on KEAP1 to disrupt the
NRF2/KEAP1 complex (Dinkova-Kostova
et al. 2002) or by facilitating the release of
NRF2 through the phosphorylation of the
NRF2/KEAP1 complex (Bloom and Jaiswal
2003). These findings are largely consistent
with our present ﬁnding that iAs stabilizes the
expression of NRF2 in HaCaT cells by elon-
gating the protein half-life.
Recently, Wakabayashi et al. (2003)
demonstrated that NRF2 accumulates in the
nucleus at constitutively high levels and pro-
duces various cytoprotective genes in embry-
onic fibroblast- and liver-derived Keap1-null
mice. Surprisingly, these Keap1-deﬁcient mice
also show a thicker stratum corneum epider-
mis, abnormal keratinization, and cornifica-
tion in the esophagus and forestomach
(hyperkeratosis). K6 was found to be strongly
expressed in the esophageal epithelium of
these mice. These results indicate that K6 is
also a target gene of NRF2. In addition, the
promoter of the K6 gene bears a remarkable
sequence similarity to the K16 promoter
(Jiang et al. 1993). Therefore, we examined
whether K16 gene expression is also regulated
by NRF2. In the present study, the gene
expression and transactivation of K16 were
dramatically induced by transfection with
WT-NRF2 via in HaCaT cells, clearly
demonstrating that NRF2 acts as a direct
transcriptional regulator of the K16 gene
(Figure 6). In addition, we also showed that
transfection of HaCaT cells with WT-NRF2
induces the expression of detoxiﬁcation gene
TXN (Figure 6A). NRF2 may thus have a
major role to play in the development of
hyperkeratosis, whereas the expression and
induction of NRF2 is implicated in cell pro-
tection against a variety of genotoxic and
cytotoxic effects. Hence, based on these
results and on the findings from studies of
Keap1 knockout mice, iAs may both cause
hyperkeratosis and induce detoxification
enzymes via the modiﬁcation of NRF2. Given
that there are both beneficial and adverse
effects of NRF2 activity, caution will therefore
be needed when using antioxidants for preven-
tion and therapy. Although further investiga-
tions are needed, we believe that our ﬁndings
provide important clues for the design of
future therapies for arsenic-mediated hyper-
keratosis and for treatments involving the
molecular targeting of NRF2.
Conclusion
Our findings clearly demonstrate that the
induction of the K16 gene in human ker-
atinocytes by iAs depends on NRF2 activa-
tion. Our results thus represent a valuable
initial effort to elucidate the relationship
between the K16 gene and the NRF2 tran-
scription factor, which may be responsible for
hyperkeratosis.
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